Contraindicated in patients with overt major bleeding.
- TRADE NAME: Acova (GSK)
- INDICATIONS: Heparin-induced thrombocytopenia
- CLASS: Anticoagulant (antithrombotic), Thrombin inhibitor
- HALF-LIFE: 40–50 minutes
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Abacavir, Anticoagulants, Antiplatetlet agents, Butabarbital, Collagen (Bovine)Collagenase, Dasatinib, Ibritumomab, NSAIDs, Pentosan, Prostacyclin analogs, Salicylates, Throbolytic agents, Tositumomab & Iodine131
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
